FACTS ABOUT HEMGENIX REVEALED

Number of eligible sufferers: CDEC mentioned the uncertainty in the amount of sufferers with reasonably critical to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some clients who are categorised as obtaining moderate or reasonable condition may have a extreme bleeding